Choongwe: New quinolone compound Q-35 on clinical phase III

Published: 1999-04-27 18:40:00
Updated: 1999-04-27 18:40:00
A new quinolone antibacterial drug, Q35 (Curoxin) will be performed its phase III clinical study accorded to the ICH standards at 13 hospitals including SNU hospital, starting from April, said Choongwe on April 22.

Choongwe obtained the approval for the phase III clinical study from the KFDA a...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.